Eli Lilly Agrees to Acquire ICOS for $2.1 Billion

October 19, 2006
Patricia Van Arnum

Patricia Van Arnum was executive editor of Pharmaceutical Technology.

ePT--the Electronic Newsletter of Pharmaceutical Technology

Indianapolis, IN (Oct. 17)-Eli Lilly and Company agreed to acquire ICOS Corporation (Bothell, WA) for $2.1 billion.

Indianapolis, IN (Oct. 17)-Eli Lilly and Company (www.lilly.com) agreed to acquire ICOS Corporation (Bothell, WA, www.icos.com) for $2.1 billion.

The companies have partnered since 1998 in Lilly ICOS LLC, a joint venture that manufactures, markets and sells “Cialis” (tadalafil), an oral PDE-5 inhibitor. Cialis had global sales of $465 million in the first half of 2006. 

The deal is expected to close in late 2006 or early 2007.

Related Content:

PharmTech News | Manufacturing